Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Wilson

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
The Lancet. Haematology|April 30, 2025
Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trialMichael Northend, William Wilson, Kushani Ediriwickrema, et al.
Journal of Molecular Biology|December 27, 2019
Structural Insights Into PfARO and Characterization of its Interaction With PfAIPMichael Geiger, Chris Brown, Jan Stephan Wichers, et al.
British Journal of Cancer|December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapySanjay Popat, Adam Januszewski, Mary O'Brien, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Blood Advances|April 23, 2021
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOPToby A Eyre, William Wilson, Amy A Kirkwood, et al.
Cancers|July 13, 2024
A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial ResultsAlexa Childs, Craig Gerrand, Bernadette Brennan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2017
Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE scoreJoren Maeremans, James C Spratt, Paul Knaapen, et al.
British Journal of Haematology|October 11, 2021
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factorsWei Yee Chan, Lara Howells, William Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical CarcinomaAndrea G Rockall, Tara D Barwick, William Wilson, et al.
British Journal of Haematology|March 2, 2021
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON studyMarquita Camilleri, Maria Cuadrado, Elizabeth Phillips, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
The Lancet. Haematology|April 30, 2025
Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trialMichael Northend, William Wilson, Kushani Ediriwickrema, et al.
Journal of Molecular Biology|December 27, 2019
Structural Insights Into PfARO and Characterization of its Interaction With PfAIPMichael Geiger, Chris Brown, Jan Stephan Wichers, et al.
British Journal of Cancer|December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapySanjay Popat, Adam Januszewski, Mary O'Brien, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Blood Advances|April 23, 2021
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOPToby A Eyre, William Wilson, Amy A Kirkwood, et al.
Cancers|July 13, 2024
A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial ResultsAlexa Childs, Craig Gerrand, Bernadette Brennan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2017
Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE scoreJoren Maeremans, James C Spratt, Paul Knaapen, et al.
British Journal of Haematology|October 11, 2021
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factorsWei Yee Chan, Lara Howells, William Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical CarcinomaAndrea G Rockall, Tara D Barwick, William Wilson, et al.
British Journal of Haematology|March 2, 2021
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON studyMarquita Camilleri, Maria Cuadrado, Elizabeth Phillips, et al.
Pageof 18